vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and INSEEGO CORP. (INSG). Click either name above to swap in a different company.
INSEEGO CORP. is the larger business by last-quarter revenue ($48.4M vs $44.9M, roughly 1.1× AbCellera Biologics Inc.). INSEEGO CORP. runs the higher net margin — 1.0% vs -19.9%, a 20.9% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 0.6%). INSEEGO CORP. produced more free cash flow last quarter ($11.6M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 13.6%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.
ABCL vs INSG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $48.4M |
| Net Profit | $-8.9M | $469.0K |
| Gross Margin | — | 42.2% |
| Operating Margin | -63.7% | 2.7% |
| Net Margin | -19.9% | 1.0% |
| Revenue YoY | 788.4% | 0.6% |
| Net Profit YoY | 73.9% | 182.9% |
| EPS (diluted) | $-0.03 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $48.4M | ||
| Q3 25 | $9.0M | $45.9M | ||
| Q2 25 | $17.1M | $40.2M | ||
| Q1 25 | $4.2M | $31.7M | ||
| Q4 24 | $5.0M | $48.1M | ||
| Q3 24 | $6.5M | $54.0M | ||
| Q2 24 | $7.3M | $51.6M | ||
| Q1 24 | $10.0M | $37.5M |
| Q4 25 | $-8.9M | $469.0K | ||
| Q3 25 | $-57.1M | $1.4M | ||
| Q2 25 | $-34.7M | $507.0K | ||
| Q1 25 | $-45.6M | $-1.6M | ||
| Q4 24 | — | $-566.0K | ||
| Q3 24 | $-51.1M | $9.0M | ||
| Q2 24 | $-36.9M | $624.0K | ||
| Q1 24 | $-40.6M | $-4.5M |
| Q4 25 | — | 42.2% | ||
| Q3 25 | — | 41.6% | ||
| Q2 25 | — | 41.1% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | — | 37.3% | ||
| Q3 24 | — | 34.8% | ||
| Q2 24 | — | 36.4% | ||
| Q1 24 | — | 35.3% |
| Q4 25 | -63.7% | 2.7% | ||
| Q3 25 | -851.8% | 4.7% | ||
| Q2 25 | -290.2% | 3.2% | ||
| Q1 25 | -1479.6% | -1.3% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | -1439.4% | 1.9% | ||
| Q2 24 | -1276.2% | 3.6% | ||
| Q1 24 | -551.5% | -7.9% |
| Q4 25 | -19.9% | 1.0% | ||
| Q3 25 | -637.8% | 3.1% | ||
| Q2 25 | -203.3% | 1.3% | ||
| Q1 25 | -1077.2% | -5.0% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | -785.4% | 16.6% | ||
| Q2 24 | -504.3% | 1.2% | ||
| Q1 24 | -408.0% | -11.9% |
| Q4 25 | $-0.03 | $-0.02 | ||
| Q3 25 | $-0.19 | $0.03 | ||
| Q2 25 | $-0.12 | $-0.03 | ||
| Q1 25 | $-0.15 | $-0.16 | ||
| Q4 24 | — | $0.62 | ||
| Q3 24 | $-0.17 | $-0.06 | ||
| Q2 24 | $-0.13 | $-0.02 | ||
| Q1 24 | $-0.14 | $-0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $24.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $-4.0M |
| Total Assets | $1.4B | $93.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $24.9M | ||
| Q3 25 | $83.2M | $14.6M | ||
| Q2 25 | $92.4M | $13.2M | ||
| Q1 25 | $159.3M | $35.1M | ||
| Q4 24 | $156.3M | $39.6M | ||
| Q3 24 | $126.6M | $12.0M | ||
| Q2 24 | $148.3M | $49.0M | ||
| Q1 24 | $123.6M | $12.3M |
| Q4 25 | $966.9M | $-4.0M | ||
| Q3 25 | $964.0M | $-7.7M | ||
| Q2 25 | $1.0B | $-10.5M | ||
| Q1 25 | $1.0B | $-13.0M | ||
| Q4 24 | $1.1B | $-12.9M | ||
| Q3 24 | $1.1B | $-85.1M | ||
| Q2 24 | $1.1B | $-101.8M | ||
| Q1 24 | $1.1B | $-105.6M |
| Q4 25 | $1.4B | $93.8M | ||
| Q3 25 | $1.4B | $85.8M | ||
| Q2 25 | $1.4B | $83.1M | ||
| Q1 25 | $1.3B | $93.0M | ||
| Q4 24 | $1.4B | $100.0M | ||
| Q3 24 | $1.4B | $113.4M | ||
| Q2 24 | $1.4B | $149.6M | ||
| Q1 24 | $1.5B | $122.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $12.0M |
| Free Cash FlowOCF − Capex | $-44.6M | $11.6M |
| FCF MarginFCF / Revenue | -99.4% | 24.0% |
| Capex IntensityCapex / Revenue | 21.9% | 0.7% |
| Cash ConversionOCF / Net Profit | — | 25.50× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $12.0M | ||
| Q3 25 | $-52.6M | $3.2M | ||
| Q2 25 | $-32.4M | $-4.5M | ||
| Q1 25 | $-11.6M | $-3.5M | ||
| Q4 24 | $-108.6M | $-14.2M | ||
| Q3 24 | $-28.9M | $14.8M | ||
| Q2 24 | $-30.0M | $27.6M | ||
| Q1 24 | $-41.7M | $5.2M |
| Q4 25 | $-44.6M | $11.6M | ||
| Q3 25 | $-61.5M | $3.1M | ||
| Q2 25 | $-45.8M | $-4.7M | ||
| Q1 25 | $-22.2M | $-3.5M | ||
| Q4 24 | $-187.0M | $-14.3M | ||
| Q3 24 | $-47.4M | $14.8M | ||
| Q2 24 | $-50.1M | $27.6M | ||
| Q1 24 | $-65.8M | — |
| Q4 25 | -99.4% | 24.0% | ||
| Q3 25 | -687.0% | 6.7% | ||
| Q2 25 | -267.9% | -11.6% | ||
| Q1 25 | -524.0% | -11.0% | ||
| Q4 24 | -3702.8% | -29.7% | ||
| Q3 24 | -728.4% | 27.4% | ||
| Q2 24 | -683.8% | 53.5% | ||
| Q1 24 | -661.5% | — |
| Q4 25 | 21.9% | 0.7% | ||
| Q3 25 | 99.7% | 0.2% | ||
| Q2 25 | 78.2% | 0.5% | ||
| Q1 25 | 251.1% | 0.1% | ||
| Q4 24 | 1552.7% | 0.1% | ||
| Q3 24 | 284.6% | 0.0% | ||
| Q2 24 | 274.6% | 0.0% | ||
| Q1 24 | 242.5% | 0.0% |
| Q4 25 | — | 25.50× | ||
| Q3 25 | — | 2.22× | ||
| Q2 25 | — | -8.81× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.65× | ||
| Q2 24 | — | 44.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
